Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells [PDF]
Yan-Ting Zhou +7 more
openalex +1 more source
Advancing Clinical Medicine with Raman Spectroscopy: Current Trends and Future Perspectives
Raman spectroscopy and microscopy may become excellent tools in clinical medicine, including hematology, oncology, infectious diseases, neurology, gastroenterology, reproductive medicine, rheumatology, and cardiovascular research. However, many challenges such as signal interference, standardization issues, and limited clinical application need to be ...
Jiří Bufka +5 more
wiley +1 more source
Stellate cells are in utero markers of pancreatic disease in cystic fibrosis. [PDF]
Leir SH +16 more
europepmc +1 more source
Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases. [PDF]
Pierre Laurent–Puig +8 more
openalex +1 more source
Early Pancreatic Cancer Diagnosis via Ultrasensitive THz Toroidal Metasensing
This study introduces a revolutionary terahertz metasurface biosensor using gold nanoparticles to boost sensitivity. It achieves precise detection of ultra‐low biomarker concentrations (1–1000 pg mL−1) with a 97.6 GHz/RIU sensitivity through optimized antibody binding.
Peng Wang +8 more
wiley +1 more source
European Registry of Hereditary Pancreatic Diseases (EUROPAC): protocol for primary and secondary screening in individuals with inherited pancreatic disease syndromes for pancreatic ductal adenocarcinoma and complications of other pancreatic diseases. [PDF]
Boughey A +12 more
europepmc +1 more source
Total Parenteral Nutrition in Pancreatic Disease
John P. Grant +3 more
openalex +2 more sources
Association between pancreatic cystadenocarcinoma, malignant liver cysts, and polycystic disease of the kidney [PDF]
Yaron Niv +3 more
openalex +1 more source
ST6GAL1 plays a critical role in tumor progression and immune regulation in colorectal cancer (CRC). Its depletion significantly suppresses the malignant phenotype of CRC cells and enhances the efficacy of anti‐PD‐L1 therapy. High ST6GAL1 expression promotes an immune‐activated tumor microenvironment (TME), characterized by increased infiltration of ...
Ximo Xu +15 more
wiley +1 more source

